153 related articles for article (PubMed ID: 34125930)
1. Patients with heart failure and an implanted cardioverter-defibrillator during the coronavirus disease 2019 pandemic: insights from a multicenter registry in Poland.
Tajstra M; Wojtaszczyk A; Sterliński M; Świerżyńska E; Szumowski Ł; Tomasiuk M; Grabowski M; Januszkiewicz ŁJ; Romanek J; Przybylski A; Mitkowski P; Klotzka A; Szafranek A; Gąsior M; Kalarus Z; Kowalski O
Kardiol Pol; 2021; 79(5):562-565. PubMed ID: 34125930
[No Abstract] [Full Text] [Related]
2. The increased rate of life-threatening interventions in remotely monitored patients with heart failure during the coronavirus disease 2019 pandemic.
Tajstra M; Kurek A; Pyka Ł; Gąsior M
Pol Arch Intern Med; 2020 Oct; 130(10):913-914. PubMed ID: 32643914
[No Abstract] [Full Text] [Related]
3. Outcomes for patients with implanted cardioverter-defibrillators admitted to the Emergency Department due to electrical shock during the pre-pandemic and COVID-19 era.
Biel B; Skoczyński P; Hrymniak B; Jakobson R; Kuliczkowski W; Obremska M; Sokołowski J; Zyśko D; Banasiak W; Jagielski D
Kardiol Pol; 2024; 82(2):156-165. PubMed ID: 38230463
[TBL] [Abstract][Full Text] [Related]
4. Spanish Implantable Cardioverter-defibrillator Registry. 17th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2020).
Fernández Lozano I; Osca Asensi J; Alzueta Rodríguez J
Rev Esp Cardiol (Engl Ed); 2021 Nov; 74(11):971-982. PubMed ID: 34583912
[TBL] [Abstract][Full Text] [Related]
5. Heart failure management in Polish medical centers during the coronavirus disease 2019 pandemic: results of a survey.
Lelonek M; Książczyk M; Pawlak A; Gąsior M; Rozentryt P; Nessler J
Kardiol Pol; 2020 Oct; 78(10):1035-1038. PubMed ID: 32847342
[No Abstract] [Full Text] [Related]
6. Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis.
Filipecki A; Orszulak M; Tajstra M; Kowalski O; Skrzypek M; Kalarus Z; Gąsior M; Mizia-Stec K
Cardiol J; 2022; 29(1):27-32. PubMed ID: 34931693
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 Pandemic on Total Mortality in Poland.
Barański K; Brożek G; Kowalska M; Kaleta-Pilarska A; Zejda JE
Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33924261
[TBL] [Abstract][Full Text] [Related]
8. Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey.
McIlvennan CK; Allen LA; Devore AD; Granger CB; Kaltenbach LA; Granger BB
J Card Fail; 2020 Jul; 26(7):635-636. PubMed ID: 32505814
[No Abstract] [Full Text] [Related]
9. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
[TBL] [Abstract][Full Text] [Related]
10. [Telemedicine in Rhythmology - Prepared for Pandemics].
Roten L
Praxis (Bern 1994); 2020; 109(14):1135-1140. PubMed ID: 33108998
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Status Among Heart Failure Patients With Implantable Cardioverter Defibrillators Before, During, and After COVID-19 Lockdown.
Lu Y; Jones PW; Caraballo C; Mahajan S; Massey DS; Ahmed R; Bader EM; Krumholz HM
J Card Fail; 2022 Aug; 28(8):1372-1374. PubMed ID: 35690314
[No Abstract] [Full Text] [Related]
12. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
Herman M; Horner K; Ly J; Vayl Y
J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
[TBL] [Abstract][Full Text] [Related]
13. [Heart Failure hospitalization during COVID-19 pandemic].
González Manzanares R; Pericet Rodríguez C; Gallo Fernández I; Castillo Domínguez JC; Anguita Sánchez M
Semergen; 2020 Aug; 46 Suppl 1():91-92. PubMed ID: 32646732
[No Abstract] [Full Text] [Related]
14. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
16. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
[TBL] [Abstract][Full Text] [Related]
17. The patient with heart failure in the face of the coronavirus disease 2019 pandemic: an expert opinion of the Heart Failure Working Group of the Polish Cardiac Society.
Kałużna-Oleksy M; Gackowski A; Jankowska EA; Kukulski T; Lelonek M; Nessler J; Pawlak A; Rozentryt P; Rubiś P; Straburzyńska-Migaj E; Leszek P
Kardiol Pol; 2020 Jun; 78(6):618-631. PubMed ID: 32418414
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
19. Impact of the COVID-19 lockdown on the arrhythmic burden of patients with implantable cardioverter-defibrillators.
Sassone B; Virzì S; Bertini M; Pasanisi G; Manzoli L; Myers J; Grazzi G; Muser D
Pacing Clin Electrophysiol; 2021 Jun; 44(6):1033-1038. PubMed ID: 34022067
[TBL] [Abstract][Full Text] [Related]
20. Why Automated E-Counseling for Chronic Heart Failure Matters in the COVID-19 Pandemic Era.
Reid KRY
Circ Heart Fail; 2021 Jan; 14(1):e008071. PubMed ID: 33464946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
